Patritumab Deruxtecan
Antibody Drug Conjugate
Overview
Patritumab Deruxtecan is a antibody drug conjugate active pharmaceutical ingredient (ChEMBL CHEMBL4594611).
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.